The Effect of 6 Months’ Treatment With Pasireotide LAR on Glucose Metabolism in Patients With Resistant Acromegaly in Real-World Clinical Settings

OBJECTIVE: The aim of the study was to evaluate glucose metabolism, as measured by glycated hemoglobin (HbA1c) levels and the need for antidiabetic medical treatment, in patients with acromegaly resistant to first-generation somatostatin receptors ligands (SRLs) treated with pasireotide long-acting...

Descripción completa

Detalles Bibliográficos
Autores principales: Witek, Przemysław, Bolanowski, Marek, Szamotulska, Katarzyna, Wojciechowska-Luźniak, Agnieszka, Jawiarczyk-Przybyłowska, Aleksandra, Kałużny, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988223/
https://www.ncbi.nlm.nih.gov/pubmed/33776927
http://dx.doi.org/10.3389/fendo.2021.633944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988223/
https://www.ncbi.nlm.nih.gov/pubmed/33776927
http://dx.doi.org/10.3389/fendo.2021.633944

Ejemplares similares